Stephen Pennington's Biography

Stephen Pennington, Professor, University College Dublin

Steve is currently Professor of Proteomics in the School of Medicine and Medical Science and the UCD Conway Institute of Biomolecular and Biomedical Research at University College Dublin. He is a lead investigator in the Dublin based ‘Prostate Cancer Research Consortium’ and a member of the first Global Action Plan initiative launched by Movember. His team (www.biomedicalproteomics.org) work closely with clinical colleagues to apply label-free LC-MS strategies to discover protein biomarkers to meet specific unmet needs in specific disease areas. To progress these biomarkers to potential clinical diagnostic assays he has established a dedicated mass spectrometry laboratory for targeted multiplexed protein biomarker measurement and clinical evaluation.

Proteomic and Bioinformatic Approaches to the Development of Biomarker Signatures of Clinical Utility for Prostate Cancer: From Discovery to Targeted Verification

Wednesday, 17 October 2012 at 16:15

Add to Calendar ▼2012-10-17 16:15:002012-10-17 17:15:00Europe/LondonProteomic and Bioinformatic Approaches to the Development of Biomarker Signatures of Clinical Utility for Prostate Cancer: From Discovery to Targeted VerificationSELECTBIOenquiries@selectbiosciences.com

Prostate cancer (PCa) is the most common male cancer and third leading cause of cancer deaths among men in western world. Current tests for PCa have limited predictive capabilities. We have undertaken a label-free LC-MS/MS and MRM workflow for the discovery and verification of biomarker signatures of potential clinical utility for PCa patient management.

Add to Calendar ▼2012-10-16 00:00:002012-10-17 00:00:00Europe/LondonCancer ProteomicsSELECTBIOenquiries@selectbiosciences.com

Conference Sponsors